Company:  ADAMIS PHARMACEUTICALS CO ... (ADMP)
Form Type:  424B5
Filing Date:  2/24/2020 
CIK:  0000887247 
Address:  11682 EL CAMINO REAL
SUITE 300
 
City, State, Zip:  SAN DIEGO, California 92130 
Telephone:  (858) 997-2400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.49  
Change: 
0.004 (0.88%)  
Trade Time: 
May 29  
Market Cap: 
$36.35M
Trade ADMP now with 

© 2020  
Description of Business
Adamis Pharmaceuticals Corporation ("we," "us," "our," "Adamis" or the "company") is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy and opioid overdose. Our products and product candidates in the allergy, respiratory, and opioid overdose markets include: SYMJEPI(TM) (epinephrine) Injection 0.3mg, which was approved by the U.S.
Register and access this filing in:     
  FORM 424B5
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS SUPPLEMENT
    CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS
    THE OFFERING
    RISK FACTORS
    USE OF PROCEEDS
    DIVIDEND POLICY
    DILUTION
    PLAN OF DISTRIBUTION
    Transfer Agent and Registrar
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    Use of Proceeds
    RISK FACTORS
    USE OF PROCEEDS
    DESCRIPTION OF CAPITAL STOCK
    DESCRIPTION OF WARRANTS
    DESCRIPTION OF UNITS
      INCORPORATION OF DOCUMENTS BY REFERENCE